文献速递神经介入DSA

Pipeline血流导向装置置入后内皮化与血管重构的综合分析

Comprehensive Analysis of Post-Pipeline Endothelialization and Remodeling.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-07-08

研究连续100例未破裂、未经治疗、非夹层动脉瘤患者,置入Pipeline Embolization Device with Shield Technology后行2D DSA随访,量化靶血管尺寸、装置直径及新生内膜厚度。新生内膜平均厚度0.3 mm(SD 0.1 mm),与年龄负相关;管腔因内膜增生缩窄被血管外向重构(扩张)抵消,重构后动脉直径较基线减少15%(SD 10%),未观察到临床相关狭窄。

要点

  • 新生内膜平均厚度0.3 mm(SD 0.1 mm,范围0.1-0.7 mm),与年龄负相关,与血管尺寸、吸烟、性别及血小板抑制程度无关。
  • 靶血管外向重构(扩张)可抵消新生内膜增生所致管腔缩窄,重构后动脉直径较基线减少15%(SD 10%),未观察到临床相关狭窄。
  • 外向重构程度与置入装置直径相对于靶血管直径呈直接线性、统计学显著关系。

核心结论

  • 血管愈合包括外向重构和新生内膜增生两个过程;在特定情形下适度 oversizing 可能有助于抵消置入后新生内膜增生所致管腔缩窄,但需与 oversized 装置金属覆盖率下降相权衡。

研究设计与样本

  • 连续100例未破裂、既往未经治疗、非夹层动脉瘤成人患者,置入Pipeline Embolization Device with Shield Technology,并有随访常规血管造影,采用2D DSA成像分析;记录并分析靶血管尺寸、装置直径、内皮厚度及人口学、抗血小板和装置相关参数。

关键影像表现/征象

  • 新生内膜增生平均厚度0.3 mm(SD 0.1 mm,范围0.1-0.7 mm),与年龄呈负相关。
  • 新生内膜增生所致管腔直径减小被靶动脉段外向重构(扩张)抵消,导致置入装置直径增加、长度相应缩短(foreshortening)。
  • 该生理性重构过程见于置入位置理想的装置,并非牵拉、装置移位或血管痉挛等所致。
  • 重构后动脉直径较基线减少15%(SD 10%),呈正态分布;未观察到临床相关狭窄。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Successful post-flow-diverter endoluminal reconstruction is widely believed to require endothelial overgrowth of the aneurysmal inflow zone. However, endothelialization/neointimal overgrowth is a complex process, over which we currently have very limited influence. Less emphasized is vascular remodeling of the target arterial segment, the dynamic response of the vessel to flow-diverter implantation. This process is distinct from flow modifications in covered branches. It appears that basic angiographic methods allow simple and useful observations. The purpose of this article was to quantitatively evaluate observable postimplantation changes in target vessels following deployment of Pipeline endoluminal constructs.

MATERIALS AND METHODS: One hundred consecutive adults with unruptured, previously untreated, nondissecting aneurysms treated with the Pipeline Embolization Device with Shield Technology and the availability of follow-up conventional angiography were studied with 2D DSA imaging. Target vessel size; Pipeline Embolization Device diameter; endothelial thickness; and various demographic, antiplatelet, and device-related parameters were recorded and analyzed.

RESULTS: The thickness of neointimal overgrowth (mean, 0.3 [SD, 0.1] mm; range, 0.1-0.7 mm) is inversely correlated with age and is independent of vessel size, smoking status, sex, and degree of platelet inhibition. The decrease in lumen diameter caused by neointimal overgrowth, however, appears counteracted by outward remodeling (dilation) of the target arterial segment. This leads to an increase in the diameter with a corresponding decrease in length (foreshortening) of the implanted Pipeline Embolization Device. This physiologic remodeling process affects optimally implanted devices and is not a consequence of stretching, device migration, vasospasm, and so forth. A direct, linear, statistically significant relationship exists between the degree of observed outward remodeling and the diameter of the implanted Pipeline Embolization Device relative to the target vessel. Overall, remodeled arterial diameters were reduced by 15% (SD, 10%) relative to baseline and followed a normal distribution. Clinically relevant stenosis was not observed.

CONCLUSIONS: Vessel healing involves both outward remodeling and neointimal overgrowth. Judicial oversizing could be useful in specific settings to counter the reduction in lumen diameter due to postimplant neointimal overgrowth; however, this overszing needs to be balanced against the decrease in metal coverage accompanying the use of oversized devices. Similar analysis for other devices is essential.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Sharashidze V, Raz E, Nossek E, et al. Comprehensive Analysis of Post-Pipeline Endothelialization and Remodeling. AJNR Am J Neuroradiol. 2024. PMID: 38663989. doi:10.3174/ajnr.A8228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。